Ann: Ryoncil Highlighted at Tandem Transplantation Meetings, page-130

  1. 292 Posts.
    lightbulb Created with Sketch. 196
    The last paragraph of the first section excludes allogeneic stem cells and Ryoncil is exactly that.

    'This document does not address: stem cell therapy used for disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment (including transplantation of autologous or allogeneic stem cells), or autologous hematopoietic stem cell-based gene therapy.'
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.52
Change
-0.060(2.33%)
Mkt cap ! $3.225B
Open High Low Value Volume
$2.58 $2.61 $2.50 $12.63M 4.955M

Buyers (Bids)

No. Vol. Price($)
1 8366 $2.51
 

Sellers (Offers)

Price($) Vol. No.
$2.53 8780 4
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.